ANKRD22: A Potential Drug Target and Biomarker (G118932)

Target Name: ANKRD22

NCBI ID: G118932

ANKRD22

ANKRD22: A Potential Drug Target and Biomarker

Ankyrin A22 (ANKRD22) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the stem-to-tail transition in microtubules, which are essential for the proper functioning of mitotic spindles. ANKRD22 has been shown to play a critical role in the regulation of mitotic spindle dynamics and stability, which are crucial for the proper separation of chromosomes during cell division.

The ANKRD22 gene was first identified in the X chromosome and has been shown to encode a protein that is involved in the regulation of microtubule dynamics. It is a 22-kDa protein that contains a unique domain that is specific to the ANKRD22 protein. This domain is composed of a helix-coiled structure that is involved in the regulation of microtubule stability.

Recent studies have shown that ANKRD22 is involved in the regulation of mitotic spindle stability and dynamics. It has been shown to play a critical role in the regulation of the length and stability of microtubules, which are essential for the proper functioning of the mitotic spindle. Additionally, ANKRD22 has been shown to regulate the dynamics of the centrosome, which is a structure that is responsible for the proper organization of chromosomes during cell division.

The ANKRD22 gene has also been shown to be involved in the regulation of gene expression. Studies have shown that ANKRD22 can interact with various transcription factors, including DNMTs (DNA methyltransferases) and RNA polymerases. This suggests that ANKRD22 may be involved in the regulation of gene expression and that it may serve as a potential drug target.

In addition to its potential drug target and biomarker properties, ANKRD22 has also been shown to have potential therapeutic applications. Studies have shown that ANKRD22 can be expressed and purified from various cell types, including cancer cells. Additionally, ANKRD22 has been shown to be involved in the regulation of mitotic spindle dynamics, which may be relevant to the treatment of various types of cancer.

In conclusion, ANKRD22 is a non-coding RNA molecule that has been shown to play a critical role in the regulation of mitotic spindle dynamics and stability. Its unique domain and potential involvement in the regulation of gene expression make it a promising candidate for drug targeting. Further research is needed to fully understand the role of ANKRD22 in the regulation of mitotic spindle dynamics and to explore its potential therapeutic applications.

Protein Name: Ankyrin Repeat Domain 22

The "ANKRD22 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD22 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets